PDL BioPharma Inc. | Key People and Executives
John Peter McLaughlin
Chief Executive Officer & Director
Elizabeth G. O'Farrell
Director
Shlomo Yanai
Independent Director
Jody S. Lindell
Independent Director
Paul W. Sandman
Independent Director
Harold E. Selick
Lead Independent Director
David W. Gryska
Independent Director
Paul R. Edick
Independent Director
Samuel R. Saks
Independent Director
John Peter McLaughlin
Chief Executive Officer & Director
Dominique Monnet
President
Peter S. Garcia
Chief Financial Officer & Vice President
Jill M. Jene
Vice President-Business Development
Elizabeth G. O'Farrell
Director
Christopher Lewis Stone
Secretary, Vice President & General Counsel
Shlomo Yanai
Independent Director
Jody S. Lindell
Independent Director
Paul W. Sandman
Independent Director
Harold E. Selick
Lead Independent Director
David W. Gryska
Independent Director
Paul R. Edick
Independent Director
Samuel R. Saks
Independent Director
| Address |
932 Southwood Boulevard
Incline Village Nevada 89451
United States
|
|
Employees
|
- |
| Website |
http://www.pdl.com |
| Updated |
07/08/2019 |
| PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. |
